Coming from diverse departments and backgrounds, our employees work together to do more than they ever thought possible – with the shared goal of making genomics accessible to all.
Illumina
Biotechnology Research
San Diego, CA 466,969 followers
Unlocking the Power of the Genome
About us
At Illumina, our goal is to apply innovative technologies and revolutionary assays to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. These studies will help make the realization of personalized medicine possible. With such rapid advances in technology taking place, it is mission critical to have solutions that are not only innovative, but flexible, scalable, and complete with industry-leading support and service. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and prioritizing the needs of its customers, we strive to meet this challenge. Illumina’s innovative, array-based solutions for DNA, RNA, and protein analysis serve as tools for disease research, drug development, and the development of molecular tests in the clinic.
- Website
-
http://www.illumina.com
External link for Illumina
- Industry
- Biotechnology Research
- Company size
- 5,001-10,000 employees
- Headquarters
- San Diego, CA
- Type
- Public Company
- Founded
- 1998
Products
BaseSpace Clarity LIMS
Laboratory Information Management Systems (LIMS)
BaseSpace Clarity LIMS is a laboratory information management system that helps genomics labs track samples and manage workflows for an optimized and efficient lab.
Locations
Employees at Illumina
Updates
-
We are proud to have ranked #5 on the inaugural TIME's World’s Most Sustainable Companies list, highlighting the incredible work being done by employees around the globe to make our operations, supply chain, and products more sustainable, including: ✅ 53% reduction in packaging ✅ 8% decrease in water usage (YoY) ✅ 100% of global electricity consumption from renewable sources
-
How to implement genomics in the clinic? Illumina was joined by 12 health system leaders to discuss strategies for boosting patient engagement, reporting results, and improving health outcomes. Learn more: https://bit.ly/4cczlc9
Illumina helps pioneering health systems deliver precision medicine
illumina.com
-
Happy Juneteenth! Not sure how to honor this holiday? Tracey Cooper, Associate Director of DEI and Jarret Southern, CGBP, Sr. Staff Program Manager share the importance of Juneteenth and how you can celebrate. #IlluminaProud
-
Find answers to your boldest research questions, expand the scope of your experimental studies and get untapped insights into biological phenomena, pathways and systems with next-generation sequencing: https://bit.ly/3VGqGZP What will you use next-generation sequencing for?
-
We are excited to share that Illumina has been included on the U.S. News & World Report Best Companies to Work For list for the second consecutive year! Thank you to our employees for fostering an innovative, inclusive, and passionate culture that enables our customers to improve human health through the power of genomics. #IlluminaProud
Best Companies to Work For | US News
money.usnews.com
-
48 hours. 122 experts. 260 datasets. 10 new diagnoses. We’re proud to participate in and sponsor #UndiagnosedHackathon2024 to help solve what had been previously deemed ‘unsolvable.’
The possibilities brought about by collaboration have never been more obvious to me than in the extraordinary initiative, that is the brainchild of Cederroth Helene and Mikk Cederroth of the Wilhelm Foundation. The #UndiagnosedHackathon2024 brought together over 122 experts from clinical genetics, patient advocacy through to computational biologists, AI and data experts from 28 countries to interrogate over 260 datasets - all with one purpose: to solve what had been previously deemed 'unsolveable'. I had the enormous privilege of opening the Undiagnosed Hackathon at the preliminary Tools Workshop. The work diagnosis does for people living with rare undiagnosed disease needed no introduction. Whilst receiving a diagnosis is never easy, it holds the possibility of care. Care is both a burden or responsibility, and an aspirational vision. Care holds the ability to cry out, to challenge stigma and to create new possibilities. The Undiagnosed Hackathon, was perhaps the most unified and significant act of care in the field of rare disease diagnosis that I have witnessed. Some of you know that I am also passionate about work that includes 'patients sitting at the front'. There was no moment more moving than when the local families joined us to start, yes, at the front. For the 26 families for whom new datasets were generated and the further 16 families for whom existing datasets were reanalysed, teams poured over clinical data, short read and long read whole genomes, transcriptomes, optical genome maps and in 48 hours provided ten new diagnoses (each with their own story of value), and found a further 9 possible diagnoses. Thank you to Mikk and Helene for compelling us to care. Thank you to the families and clinicians who put their hope in this venture. Thank you to the team at Nijmegen for your leadership and enthusiasm (Wendy van Zelst-Stams, Lisenka Vissers, Alexander Hoischen) and thank you to this team of extraordinary friends (old and new): Orion Buske, Alistair Ward, Drew Ellershaw, Holly Zheng Bradley, Gareth Baynam, Shahida Moosa, Elizabeth Emma Palmer, Michael Eberle, Samuel Wiafe, AIME LUMAKA, Raquel Peck, Tania Simoncelli, Shinya Yamamoto, Jennifer Gardner, Ann Nordgren, Steve Laurie, Pablo Botas, Salman Kirmani, Rocío Acuña Hidalgo and many more.
Undiagnosed Hackathon Day2
https://www.youtube.com/
-
Welcome to Illumina, Everett Cunningham! 🧬
I am thrilled to welcome Everett Cunningham to the Illumina leadership team, as we work to deliver on our #mission to improve human health by unlocking the power of the genome. He brings tremendous commercial leadership experience to the role, along with a passion for solving some of the world’s most pressing healthcare challenges. I look forward to seeing all that Everett and our global teams can do, capitalizing on our industry-leading next generation sequencing technology, and delivering the products, services, and solutions that address customers’ most pressing needs.
-
-
Illumina reposted this
Illumina Connected Insights version 4.0 is out! Now supporting variant interpretation for somatic oncology assays at scale, enabling - powerful visualizations of fusions and other variants called from #DRAGEN; integration of #OncoKB, and more than 55 other knowledge sources; and new automation to help predict #oncogenicity based on recent guidelines. #Oncology #NGS #Bioinformatics #Interpretation https://lnkd.in/gBR5syP6 #sequencing #bioinformatics Illumina
-
Affiliated pages
Similar pages
Browse jobs
Stock
ILMN
NASDAQ
20 minutes delay
$105.24
0.858 (0.822%)
- Open
- 104.19
- Low
- 103.57
- High
- 108.43
Data from Refinitiv
See more info on